Oki N. Putra

Surabaya, JI, Indonesia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Depression Level and Quality of Life between Shorter and Longer Regimens among Patients with Multidrug-resistant Tuberculosis.

Depression Level and Quality of Life between Shorter and Longer Regimens among Patients with Multidrug-resistant Tuberculosis.

Journal: International journal of mycobacteriology

Published: March 02, 2026

Bedaquiline or delamanid improves the quality of life among patients with drug-resistant tuberculosis.

Bedaquiline or delamanid improves the quality of life among patients with drug-resistant tuberculosis.

Journal: Journal of family medicine and primary care

Published: November 23, 2024

Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients.

Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients.

Journal: International journal of mycobacteriology

Published: August 25, 2024

Pyrazinamide-induced Hyperuricemia in Pulmonary Tuberculosis Patients.

Pyrazinamide-induced Hyperuricemia in Pulmonary Tuberculosis Patients.

Journal: International journal of mycobacteriology

Published: May 20, 2024

Treatment Outcomes of Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: An Implication for Delamanid.

Treatment Outcomes of Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: An Implication for Delamanid.

Journal: Tuberculosis and respiratory diseases

Published: November 24, 2023

Baseline glycated hemoglobin and potassium level correlated with pretreatment QT-corrected interval among patients with diabetic drug-resistant tuberculosis.

Baseline glycated hemoglobin and potassium level correlated with pretreatment QT-corrected interval among patients with diabetic drug-resistant tuberculosis.

Journal: International journal of mycobacteriology

Published: September 18, 2023

Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review.

Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review.

Journal: International journal of mycobacteriology

Published: March 17, 2023

Effectiveness and safety of regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis.

Effectiveness and safety of regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis.

Journal: Perspectives in clinical research

Published: January 02, 2023

Scoping review: QT interval prolongation in regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis.

Scoping review: QT interval prolongation in regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis.

Journal: International journal of mycobacteriology

Published: December 13, 2022

Factors associated with treatment outcomes in drug-resistant tuberculosis.

Factors associated with treatment outcomes in drug-resistant tuberculosis.

Journal: International journal of mycobacteriology

Published: July 01, 2022

Anemia related to linezolid-based combination regimen in drug-resistant tuberculosis.

Anemia related to linezolid-based combination regimen in drug-resistant tuberculosis.

Journal: International journal of mycobacteriology

Published: March 17, 2022

Should we still consider colchicine in treating patients with COVID-19?

Should we still consider colchicine in treating patients with COVID-19?

Journal: European review for medical and pharmacological sciences

Published: March 07, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026